Product Information
SILDENAFIL 20 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0519 per EA under NDC 59762003303. Its NADAC has been published 282 times since Mar 10, 2021.
FDA first approved this application on Jun 3, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762003303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
SILDENAFIL CITRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021845FDA Approved
6/3/2005
TE Code
AB
On Market Since
9/27/2012
Pharmacological Classes
Price Statistics
The NADAC for SILDENAFIL 20 MG TABLET has been published 282 times since Mar 10, 2021, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0519 per EA |
|---|---|
| All-time high | $0.1406 (Apr 14, 2021) |
| All-time low | $0.0441 (Nov 20, 2024) |
| 52-week high | $0.0730 |
| 52-week low | $0.0514 |
| Median price | $0.0748 |
| Average price | $0.0775 |
| Largest weekly change | -46.9% (Nov 20, 2024) |
| Weeks tracked | 282 |
| Tracking since | Mar 10, 2021 |
1W
N/A
1M
N/A
3M
-2.7%
6M
-2.2%
1Y
-29.0%
3Y
-30.6%
5Y
-47.8%
All
-49.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sildenafil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sildenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SILDENAFIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SILDENAFIL 20 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0519 per EA (NDC 59762003303), effective Jul 29, 2026.
How has the price of SILDENAFIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for SILDENAFIL 20 MG TABLET has declined 49.0%. It has been tracked across 282 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for SILDENAFIL 20 MG TABLET?
Since Mar 10, 2021, the NADAC for SILDENAFIL 20 MG TABLET has ranged from a low of $0.0441 (Nov 20, 2024) to a high of $0.1406 (Apr 14, 2021), with a median of $0.0748 per EA.
Are there cheaper alternatives to SILDENAFIL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SILDENAFIL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SILDENAFIL 20 MG TABLET?
SILDENAFIL 20 MG TABLET (NDC 59762003303) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.